Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.
Retroviruses and opportunistic infections - ninth conference. New antiviral agents. 24-28 February, Seattle, WA, USA.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.
TAK-779 (Takeda).